185 related articles for article (PubMed ID: 8825886)
1. Sensory gating deficits in parents of schizophrenics.
Waldo M; Myles-Worsley M; Madison A; Byerley W; Freedman R
Am J Med Genet; 1995 Dec; 60(6):506-11. PubMed ID: 8825886
[TBL] [Abstract][Full Text] [Related]
2. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia.
Myles-Worsley M; Ord L; Blailes F; Ngiralmau H; Freedman R
Biol Psychiatry; 2004 Apr; 55(7):663-7. PubMed ID: 15038993
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
Moxon KA; Gerhardt GA; Adler LE
Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
[TBL] [Abstract][Full Text] [Related]
4. [P50 component of auditory evoked potentials in persons with schizophrenia and their first degree relatives].
Wegrzyn J; Wciórka J
Psychiatr Pol; 2004; 38(3):395-408. PubMed ID: 15199650
[TBL] [Abstract][Full Text] [Related]
5. Exploration of somatosensory P50 gating in schizophrenia spectrum patients: reduced P50 amplitude correlates to social anhedonia.
Arnfred SM; Chen AC
Psychiatry Res; 2004 Feb; 125(2):147-60. PubMed ID: 15006438
[TBL] [Abstract][Full Text] [Related]
6. Evidence for bilineal inheritance of physiological indicators of risk in childhood-onset schizophrenia.
Ross RG; Olincy A; Harris JG; Radant A; Hawkins M; Adler LE; Freedman R
Am J Med Genet; 1999 Apr; 88(2):188-99. PubMed ID: 10206241
[TBL] [Abstract][Full Text] [Related]
7. P50 inhibitory gating deficit is correlated with the negative symptomatology of schizophrenia.
Louchart-de la Chapelle S; Levillain D; Ménard JF; Van der Elst A; Allio G; Haouzir S; Dollfus S; Campion D; Thibaut F
Psychiatry Res; 2005 Jul; 136(1):27-34. PubMed ID: 16014313
[TBL] [Abstract][Full Text] [Related]
8. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia.
Sánchez-Morla EM; García-Jiménez MA; Barabash A; Martínez-Vizcaíno V; Mena J; Cabranes-Díaz JA; Baca-Baldomero E; Santos JL
Acta Psychiatr Scand; 2008 Apr; 117(4):313-8. PubMed ID: 18241306
[TBL] [Abstract][Full Text] [Related]
9. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients.
Brockhaus-Dumke A; Schultze-Lutter F; Mueller R; Tendolkar I; Bechdolf A; Pukrop R; Klosterkoetter J; Ruhrmann S
Biol Psychiatry; 2008 Sep; 64(5):376-84. PubMed ID: 18395700
[TBL] [Abstract][Full Text] [Related]
10. [P50 sensory gating disorders of auditory evoked potentials (AEP) in persons with schizophrenia].
Wegrzyn J
Psychiatr Pol; 2004; 38(5):833-45. PubMed ID: 15523930
[TBL] [Abstract][Full Text] [Related]
11. Gating of auditory P50 in schizophrenics: unique effects of clozapine.
Nagamoto HT; Adler LE; Hea RA; Griffith JM; McRae KA; Freedman R
Biol Psychiatry; 1996 Aug; 40(3):181-8. PubMed ID: 8830951
[TBL] [Abstract][Full Text] [Related]
12. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.
Boutros NN; Korzyukov O; Jansen B; Feingold A; Bell M
Psychiatry Res; 2004 May; 126(3):203-15. PubMed ID: 15157747
[TBL] [Abstract][Full Text] [Related]
13. Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects.
Rentzsch J; Jockers-Scherübl MC; Boutros NN; Gallinat J
Int J Psychophysiol; 2008 Feb; 67(2):81-90. PubMed ID: 18053603
[TBL] [Abstract][Full Text] [Related]
14. [The follow-up study on P50 auditory sensory gating in naïve schizophrenia].
Wang HX; Zhang MD; Wang ZC; Chen XS; Lou FY; Liang JH; Chen C
Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):601-5. PubMed ID: 20450782
[TBL] [Abstract][Full Text] [Related]
15. P50 gating at acute and post-acute phases of first-episode schizophrenia.
Devrim-Uçok M; Keskin-Ergen HY; Uçok A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1952-6. PubMed ID: 18929611
[TBL] [Abstract][Full Text] [Related]
16. Auditory sensory gating deficit and cortical thickness in schizophrenia.
Thoma RJ; Hanlon FM; Sanchez N; Weisend MP; Huang M; Jones A; Miller GA; Canive JM
Neurol Clin Neurophysiol; 2004 Nov; 2004():62. PubMed ID: 16012689
[TBL] [Abstract][Full Text] [Related]
17. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment.
Cadenhead KS; Light GA; Shafer KM; Braff DL
Biol Psychiatry; 2005 Jun; 57(12):1504-9. PubMed ID: 15953486
[TBL] [Abstract][Full Text] [Related]
18. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials.
Siegel SJ; Maxwell CR; Majumdar S; Trief DF; Lerman C; Gur RE; Kanes SJ; Liang Y
Neuroscience; 2005; 133(3):729-38. PubMed ID: 15908134
[TBL] [Abstract][Full Text] [Related]
19. The -2 bp deletion in exon 6 of the 'alpha 7-like' nicotinic receptor subunit gene is a risk factor for the P50 sensory gating deficit.
Raux G; Bonnet-Brilhault F; Louchart S; Houy E; Gantier R; Levillain D; Allio G; Haouzir S; Petit M; Martinez M; Frebourg T; Thibaut F; Campion D
Mol Psychiatry; 2002; 7(9):1006-11. PubMed ID: 12399955
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.
Adler LE; Pachtman E; Franks RD; Pecevich M; Waldo MC; Freedman R
Biol Psychiatry; 1982 Jun; 17(6):639-54. PubMed ID: 7104417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
